Allergy Research Group, LLC
Records under this name other than patents Allergy Research Group, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Allergy Research Group, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,421,943 | Phospholipid compositions and use thereof to enhance spermatozoa motility, viability and resistance to oxydative damage Formerly held In force (reinstated) · USPTO record | In force (reinstated) | USPTO record | |
| US 8,877,239 | LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 9,717,734 | Chewable lipid supplements containing caffeine for increasing alertness, focus and energy Formerly held Lapsed on the fee record Ended Aug 1, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 1, 2025 | USPTO record |
| US 10,874,681 | Oral lipid supplements for treating pain and fibromyalgia Formerly held Lapsed on the fee record Ended Dec 29, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 29, 2024 | USPTO record |
| US 9,468,668 | Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders Formerly held Lapsed on the fee record Ended Oct 18, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 18, 2024 | USPTO record |
| US 9,095,507 | Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders Formerly held Lapsed on the fee record Ended Aug 4, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 4, 2023 | USPTO record |
| US 10,117,885 | Chewable lipid supplements for treating pain and fibromyalgia Formerly held Lapsed on the fee record Ended Nov 6, 2022 · USPTO record | Lapsed on the fee record | Ended Nov 6, 2022 | USPTO record |
| US 9,861,656 | Phospholipid compositions and use thereof to enhance spermatozoa motility and viability Formerly held Lapsed on the fee record Ended Jan 9, 2022 · USPTO record | Lapsed on the fee record | Ended Jan 9, 2022 | USPTO record |